TauroLock™ solutions are antimicrobial (incl. MRSA & VRE), anticoagulant, and thrombolytic.
Fields of application
Where patients benefit from TauroLock™ lock solutions
Intensive care units
Patients in ICU can be treated with TauroLock™ or TauroLock™-HEP100, depending on their medical condition.
Our product range
TauroLock™ is recommended for instillation in all central-venous access systems. It prevents the formation of bacterial biofilms and improves the patency rate.
TauroLock™-U25.000 ensures a particularly strong protection against catheter-related complications. It contains taurolidine, 4 % citrate, and 25,000 IU urokinase.
TauroLock™-Hep100 is suitable for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and maintain a high patency rate.
TauroLock™-HEP500 has been developed specifically for dialysis patients. It prevents catheter-related infections and occlusions.
TauroLock™ at international events
Meet us at medical fairs and conventions across the globe
Ernährung/Nutrition Bregenz1–3 June 2023 www.nutrition-congress.at
ERA-EDTA Congress Milano15–18 June 2023 www.era-online.org
ESPEN Lyon11–14 September 2023 espencongress.com